Cancer Genetics, Inc. Announces Strategic Transactions

15 Jul 2019 - Yahoo News
Cancer Genetics, Inc. (CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today announced the sale of its BioPharma business. The Company’s junior secured lender, Partners for Growth IV, L.P. (“PFG”) conducted a consensual ...
usx:cgix

---

Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners

15 Jul 2019 - Yahoo News
Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business of Cancer Genetics, Inc. (CGIX) (the “BioPharma Business”) for approximately $23.5 million subject to certain adjustments. ...
usx:cgix

---

Triangle pharma brings in new CFO looking for capital

25 Jun 2019 - Yahoo News
Amidst a continued effort to expand, Innovate BioPharmaceuticals has brought on a full-time chief financial officer, which it hopes will lead a campaign to raise more capital to finance its clinical trials.
usx:cgix

---

Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer

24 Jun 2019 - Yahoo News
Innovate Biopharmaceuticals, Inc. (INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, today announced the appointment of Ed Sitar as its Chief Financial Officer commencing on July 1, 2019. With an expanded management team, ...
usx:cgix

---

Cancer Genetics: 1Q Earnings Snapshot

20 May 2019 - Yahoo News
The Rutherford, New Jersey-based company said it had a loss of 9 cents per share. Losses, adjusted for costs related to mergers and acquisitions, were 8 cents per share. The diagnostics company posted ...
usx:cgix

---

Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update

20 May 2019 - Yahoo News
RUTHERFORD, N.J., May 20, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics,.
usx:cgix

---

Cancer Genetics: 4Q Earnings Snapshot

16 Apr 2019 - Yahoo News
On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 14 cents. The diagnostics company posted revenue of $6.8 million in the period. For the year, the company reported that ...
usx:cgix

---

Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates

16 Apr 2019 - Yahoo News
RUTHERFORD, N.J., April 16, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics,.
usx:cgix

---

Investors Who Bought Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Are Now Down 98%

26 Mar 2019 - Yahoo News
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Long term investing is the way to go, but thatRead More...
usx:cgix

---

Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful?

14 Feb 2019 - Yahoo News
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you want to know who reallyRead More...
usx:cgix

---